Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasm Metastasis 1Hypertension 1Essential Hypertension 1

Interventions

relacorilant 3Nutrition Assessment 2ganirelix 1clevidipine 1cediranib 1benazepril 1aliskiren 1Vitamin D 1Therapeutics 1Surveys and Questionnaires 1Sulindac 1Resistance Training 1Ramipril 1Observation 1Methyltestosterone 1Methods 1Losartan 1Lisinopril 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Interviews as Topic 1Fatty Acids, Omega-3 1Enalapril 1Educational Status 1Desvenlafaxine Succinate 1Adrenalectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Hypertension × aliskiren × Clear all
NCT01151410 2016-03-07

An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age

Novartis

Phase 3 Completed
208 enrolled 10 charts

Essential Hypertension, Hypertension, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡